Full Text View
Tabular View
Study Results
Related Studies
Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer
This study has been completed.
Study NCT00452673   Information provided by Bristol-Myers Squibb

First Received on March 26, 2007.   Last Updated on December 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial